about
Micro-RNA profiling in human serum reveals compartment-specific roles of miR-571 and miR-652 in liver cirrhosisPeroxidasin is secreted and incorporated into the extracellular matrix of myofibroblasts and fibrotic kidneyGalectin-3 regulates myofibroblast activation and hepatic fibrosisEnteric dysbiosis associated with a mouse model of alcoholic liver diseaseCellular senescence controls fibrosis in wound healingmiRNA studies in in vitro and in vivo activated hepatic stellate cellsSenescence of activated stellate cells limits liver fibrosisLiver-specific beta-catenin knockout mice exhibit defective bile acid and cholesterol homeostasis and increased susceptibility to diet-induced steatohepatitisTNF-{alpha} plays a role in hepatocyte apoptosis in Niemann-Pick type C liver diseaseCARMA3/Bcl10/MALT1-dependent NF-kappaB activation mediates angiotensin II-responsive inflammatory signaling in nonimmune cellsAnalysis of gene expression changes in relation to toxicity and tumorigenesis in the livers of Big Blue transgenic rats fed comfrey (Symphytum officinale)The myofibroblast: one function, multiple originsCancer-associated fibroblasts in hepatocellular carcinomaPersonalized Clinical Trials in Hepatocellular Carcinoma Based on Biomarker SelectionMicroRNAs in liver fibrosis: Focusing on the interaction with hedgehog signalingTissue- and Serum-Associated Biomarkers of Hepatocellular CarcinomaEvolving Insights on Metabolism, Autophagy, and Epigenetics in Liver MyofibroblastsAnti-fibro-hepatocarcinogenic Chinese herbal medicines: A mechanistic overviewHepatic Stellate Cells and microRNAs in Pathogenesis of Liver FibrosisNew Potential Pharmacological Functions of Chinese Herbal Medicines via Regulation of AutophagyMicroRNAs as Biomarkers for Liver Disease and Hepatocellular CarcinomaThe Role of NADPH Oxidases (NOXs) in Liver Fibrosis and the Activation of MyofibroblastsNovel Molecular Mechanisms in the Development of Non-Alcoholic SteatohepatitisNatural Killer Cells and Liver FibrosisMultipotent mesenchymal stromal cells: A promising strategy to manage alcoholic liver diseaseControversies over the Epithelial-to-Mesenchymal Transition in Liver FibrosisPathogenesis of Type 2 Epithelial to Mesenchymal Transition (EMT) in Renal and Hepatic FibrosisEGFR Signaling in Liver DiseasesReversible Human TGF-β Signal Shifting between Tumor Suppression and Fibro-Carcinogenesis: Implications of Smad Phospho-Isoforms for Hepatic Epithelial-Mesenchymal TransitionsBiomarker-Based Approaches for Assessing Alcohol Use DisordersNon-invasive assessment of liver fibrosis: Between prediction/prevention of outcomes and cost-effectiveness.Role of Noncoding RNAs as Biomarker and Therapeutic Targets for Liver FibrosisTransient Elastography for Assessment of Liver Fibrosis and Steatosis: An Evidence-Based Analysis.Role of redoximiRs in fibrogenesisNon-invasive diagnosis of liver fibrosis and cirrhosis.Inflammatory status in human hepatic cirrhosisReciprocal regulation of TGF-β and reactive oxygen species: A perverse cycle for fibrosisMesenchymal stem cell therapy for liver fibrosisThe Role of Dendritic Cells in Fibrosis Progression in Nonalcoholic Fatty Liver DiseaseFrom the stomach to other organs: Helicobacter pylori and the liver
P2860
Q21560965-1662B8C6-B2AC-4624-A31C-8ABBA1385464Q24312762-6D8B2E77-8FB9-4D9C-8F42-F22B1C999794Q24546358-4031D8EB-6D77-4663-8F3F-D219B45DB9C3Q24594915-305F135B-7949-4612-BBEB-A618E59E1D6DQ24602488-13137895-5D15-4123-8837-CC9507E56C23Q24606657-D838A9CB-89F1-4FFE-8061-2CE6DAC23E0AQ24621822-F3A3EECF-616F-474E-A257-0EBAB439046EQ24645373-CAACFEAD-77EF-438F-A034-291E431D7A0FQ24657208-3D12CD2B-0298-4F44-B8C4-749FB0C08031Q24675332-D2E9627A-B78F-457C-86BF-14C989A50077Q24677312-D6ED4F60-FEFB-4602-95D8-96767DBFC258Q24683749-3B57F289-A7FB-4DC9-945A-77885AB96838Q26738536-5DF8872F-AFAA-4C24-95A6-55C17AB73928Q26738860-55D692B4-2352-4AB6-BF35-8118A658FA3FQ26740198-98F38497-4781-45B9-8B0F-17DF9AB7E718Q26743361-8F1B22B0-3C16-489D-B553-FC78B3A6AC9CQ26745566-F28CB867-11F5-4388-9ADA-F4257235FD68Q26745650-48FB1D7B-F9C0-4C6F-BC50-2BB816D0D067Q26752932-EACA49A2-D230-4372-9C68-BEB2EFDAABDEQ26753053-D24793BD-4C65-4D1D-A3DC-5A1FCEDE4EB0Q26765476-35027E6A-18F8-43BB-BFA1-360C114FCB71Q26766479-4E172BC2-667A-4A4F-8648-C5064BA898B9Q26766533-9BDE542F-4ADF-4C9A-9766-25AFB7B8FD19Q26767448-B6E76D9C-A9AD-4C28-A5F0-AA01479D4239Q26769618-4B8543D9-6EB7-4280-97A7-7724764C4D72Q26771108-91BF938C-0927-4AD6-B581-11A09F9992B7Q26771232-7D661332-2C3B-416E-B33D-1A661425DEAEQ26771265-EFE554B2-C5D9-443F-88D6-B07E2D206C55Q26771696-6C338614-9F5E-4EF0-890F-EB978D787939Q26772931-DCD61A13-FCB8-4A96-AA85-F5B04D0325F3Q26773187-BFA4C515-86AE-43A5-A7D5-57AE54AA304EQ26774309-B0AAE492-3D49-47DF-A12C-CE9B6A7FB7BFQ26776180-9AAFCA3C-54FD-46FD-9F65-257B36A7C6A8Q26776555-B15A63B2-2DC9-4B54-BCEC-FD482F63DA75Q26778033-0B28F07E-72B7-4C2F-B1AF-429B7C9DF6C7Q26778040-12B5D4EC-0DE9-4265-B134-0EE5469CB907Q26779846-D064C9FB-C0E8-4C67-AA44-89A4EFF1140DQ26782128-9866254B-29E4-49BA-9D60-4AE8D961723EQ26784452-88ABBE9E-2C91-4D95-88DC-AD140A44C72BQ26795532-77F4523A-2D40-4290-AA66-560B127BF72E
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Liver fibrosis
@ast
Liver fibrosis
@en
type
label
Liver fibrosis
@ast
Liver fibrosis
@en
prefLabel
Liver fibrosis
@ast
Liver fibrosis
@en
P2860
P3181
P1476
Liver fibrosis
@en
P2093
Ramón Bataller
P2860
P304
P3181
P356
10.1172/JCI200524282
10.1172/JCI24282
P407
P577
2005-02-01T00:00:00Z